Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
DocetaxelJ E Cortes, R Pazdur
American Journal of Clinical Oncology|December 11, 1992
Phase I study of 5-fluorouracil with folinic acid combined with recombinant human granulocyte-macrophage colony-stimulating factorD F Moore, R Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Developing drugs to decrease the toxicity of chemotherapyG Williams, P Cortazar, R Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Conflicting phase II efficacy data for DoxilG Frykman, G Williams, R Pazdur
Journal of Surgical Oncology. Supplement|January 1, 1993
Pediatric hepatic tumors: clinical trials conducted in the United StatesR Pazdur, B Bready, A Cangir
The Surgical Clinics of North America|February 1, 1997
Adjuvant medical therapy for colorectal cancerE A Diaz-Canton, R Pazdur
Medicina|January 1, 1996
[Medical treatment of colorectal cancer]E A Díaz-Cantón, R Pazdur
American Journal of Clinical Oncology|April 1, 1991
Fibrolamellar hepatocellular carcinoma. Therapeutic implications of a ten-year disease-free intervalP T Ang, H Evans, R Pazdur
Seminars in Oncology|April 11, 1992
Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trialR Pazdur, D F Moore, B Bready
Journal of Surgical Oncology|September 1, 1989
Metastatic sweat gland carcinoma: response to 5-fluorouracil infusionJ D Swanson, R Pazdur, E Sykes
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
DocetaxelJ E Cortes, R Pazdur
American Journal of Clinical Oncology|December 11, 1992
Phase I study of 5-fluorouracil with folinic acid combined with recombinant human granulocyte-macrophage colony-stimulating factorD F Moore, R Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Developing drugs to decrease the toxicity of chemotherapyG Williams, P Cortazar, R Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Conflicting phase II efficacy data for DoxilG Frykman, G Williams, R Pazdur
Journal of Surgical Oncology. Supplement|January 1, 1993
Pediatric hepatic tumors: clinical trials conducted in the United StatesR Pazdur, B Bready, A Cangir
The Surgical Clinics of North America|February 1, 1997
Adjuvant medical therapy for colorectal cancerE A Diaz-Canton, R Pazdur
Medicina|January 1, 1996
[Medical treatment of colorectal cancer]E A Díaz-Cantón, R Pazdur
American Journal of Clinical Oncology|April 1, 1991
Fibrolamellar hepatocellular carcinoma. Therapeutic implications of a ten-year disease-free intervalP T Ang, H Evans, R Pazdur
Seminars in Oncology|April 11, 1992
Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trialR Pazdur, D F Moore, B Bready
Journal of Surgical Oncology|September 1, 1989
Metastatic sweat gland carcinoma: response to 5-fluorouracil infusionJ D Swanson, R Pazdur, E Sykes
Pageof 16